223 related articles for article (PubMed ID: 18785023)
21. A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.
Kooi IE; Mol BM; Massink MP; de Jong MC; de Graaf P; van der Valk P; Meijers-Heijboer H; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
PLoS One; 2016; 11(4):e0153323. PubMed ID: 27115612
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous identification of clinically relevant
Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
[TBL] [Abstract][Full Text] [Related]
23. Secondary enucleated retinoblastoma with MYCN amplification.
Moulin AP; Stathopoulos C; Marcelli F; Schoumans Pouw J; Beck-Popovic M; Munier FL
Ophthalmic Genet; 2021 Jun; 42(3):354-359. PubMed ID: 33870828
[No Abstract] [Full Text] [Related]
24. The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.
Pajovic S; Corson TW; Spencer C; Dimaras H; Orlic-Milacic M; Marchong MN; To KH; Thériault B; Auspitz M; Gallie BL
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7618-24. PubMed ID: 21862643
[TBL] [Abstract][Full Text] [Related]
25. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma.
Corson TW; Gallie BL
Genes Chromosomes Cancer; 2007 Jul; 46(7):617-34. PubMed ID: 17437278
[TBL] [Abstract][Full Text] [Related]
26. Germline mutations in retinoma patients: relevance to low-penetrance and low-expressivity molecular basis.
Abouzeid H; Schorderet DF; Balmer A; Munier FL
Mol Vis; 2009; 15():771-7. PubMed ID: 19390654
[TBL] [Abstract][Full Text] [Related]
27. Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma.
Guo Y; Pajovic S; Gallie BL
Biochem Biophys Res Commun; 2008 Oct; 375(1):1-5. PubMed ID: 18644346
[TBL] [Abstract][Full Text] [Related]
28. Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation?
Gallie BL; Ellsworth RM; Abramson DH; Phillips RA
Br J Cancer; 1982 Apr; 45(4):513-21. PubMed ID: 7073943
[TBL] [Abstract][Full Text] [Related]
29. Silencing of the Long Noncoding RNA MYCNOS1 Suppresses Activity of MYCN-Amplified Retinoblastoma Without RB1 Mutation.
Saengwimol D; Chittavanich P; Laosillapacharoen N; Srimongkol A; Chaitankar V; Rojanaporn D; Aroonroch R; Suktitipat B; Saisawang C; Svasti S; Hongeng S; Kaewkhaw R
Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):8. PubMed ID: 33270844
[TBL] [Abstract][Full Text] [Related]
30. Constitutional genomic instability, chromosome aberrations in tumor cells and retinoblastoma.
Amare Kadam PS; Ghule P; Jose J; Bamne M; Kurkure P; Banavali S; Sarin R; Advani S
Cancer Genet Cytogenet; 2004 Apr; 150(1):33-43. PubMed ID: 15041221
[TBL] [Abstract][Full Text] [Related]
31. Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization.
Chen D; Gallie BL; Squire JA
Cancer Genet Cytogenet; 2001 Aug; 129(1):57-63. PubMed ID: 11520568
[TBL] [Abstract][Full Text] [Related]
32. Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors.
Schaub R; Burger A; Bausch D; Niggli FK; Schäfer BW; Betts DR
Cancer Genet Cytogenet; 2007 Jan; 172(1):61-5. PubMed ID: 17175381
[TBL] [Abstract][Full Text] [Related]
33. Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma.
Winter U; Ganiewich D; Ottaviani D; Zugbi S; Aschero R; Sendoya JM; Cafferata EG; Mena M; Sgroi M; Sampor C; Lubieniecki F; Fandiño A; Abba MC; Doz F; Podhjacer O; Carcaboso AM; Letouzé E; Radvanyi F; Chantada GL; Llera AS; Schaiquevich P
JAMA Ophthalmol; 2020 May; 138(5):569-574. PubMed ID: 32191268
[TBL] [Abstract][Full Text] [Related]
34. Genetics and Molecular Diagnostics in Retinoblastoma--An Update.
Soliman SE; Racher H; Zhang C; MacDonald H; Gallie BL
Asia Pac J Ophthalmol (Phila); 2017; 6(2):197-207. PubMed ID: 28399338
[TBL] [Abstract][Full Text] [Related]
35. Genomic gains on chromosome 1q in retinoblastoma: consequences on gene expression and association with clinical manifestation.
Gratias S; Schüler A; Hitpass LK; Stephan H; Rieder H; Schneider S; Horsthemke B; Lohmann DR
Int J Cancer; 2005 Sep; 116(4):555-63. PubMed ID: 15825178
[TBL] [Abstract][Full Text] [Related]
36. Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome.
Lillington DM; Kingston JE; Coen PG; Price E; Hungerford J; Domizio P; Young BD; Onadim Z
Genes Chromosomes Cancer; 2003 Feb; 36(2):121-8. PubMed ID: 12508240
[TBL] [Abstract][Full Text] [Related]
37. MRI Features for Identifying
Jansen RW; de Bloeme CM; Cardoen L; Göricke S; van Elst S; Jessen JL; Ramasubramanian A; Skalet AH; Miller AK; Maeder P; Uner OE; Hubbard GB; Grossniklaus H; Boldt HC; Nichols KE; Brennan RC; Sen S; Sirin S; Brisse HJ; Galluzzi P; Dommering CJ; Castelijns JA; van der Valk P; Boellaard R; Dorsman J; Moll AC; de Jong MC; de Graaf P
Radiology; 2023 Jun; 307(5):e222264. PubMed ID: 37191489
[TBL] [Abstract][Full Text] [Related]
38. Concomitant DDX1 and MYCN gain in neuroblastoma.
Defferrari R; Tonini GP; Conte M; Papio F; Sementa AR; Valent A; Schena F; Perri P; Mazzocco K
Cancer Lett; 2007 Oct; 256(1):56-63. PubMed ID: 17611020
[TBL] [Abstract][Full Text] [Related]
39. Gain of MYCN region in a Wilms tumor-derived xenotransplanted cell line.
Noguera R; Villamón E; Berbegall A; Machado I; Giner F; Tadeo I; Navarro S; Llombart-Bosch A
Diagn Mol Pathol; 2010 Mar; 19(1):33-9. PubMed ID: 20186010
[TBL] [Abstract][Full Text] [Related]
40. Multiple genetic loci modify risk for retinoblastoma in transgenic mice.
Griep AE; Krawcek J; Lee D; Liem A; Albert DM; Carabeo R; Drinkwater N; McCall M; Sattler C; Lasudry JG; Lambert PF
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2723-32. PubMed ID: 9856783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
